tilivalline has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T; Kohda, K; Mori, N; Shimizu, N; Shioiri, T; Yamagami, N | 1 |
| Aoyama, T; Kasamatsu, T; Kohda, K; Shioiri, T; Yamagami, N | 1 |
2 other study(ies) available for tilivalline and Leukemia L 1210
| Article | Year |
|---|---|
Structure-cytotoxicity relationship of tilivalline derivatives.
Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Cell Survival; Leukemia L1210; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Wide difference between the cytotoxicity of the 11-alpha-and 11-beta-cyano analogues of tilivalline and their epimeric conversion.
Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Cell Division; Leukemia L1210; Mice; Stereoisomerism; Tumor Cells, Cultured | 1995 |